Suppr超能文献

新型冠状病毒:面向基层医疗和急症护理医生的简要综述

Novel coronavirus: A capsule review for primary care and acute care physicians.

作者信息

Sahu Ankit Kumar, Nayer Jamshed, Aggarwal Praveen

机构信息

Department of Emergency Medicine, All India Institute of Medical Sciences, New Delhi, India.

出版信息

J Family Med Prim Care. 2020 Apr 30;9(4):1820-1824. doi: 10.4103/jfmpc.jfmpc_217_20. eCollection 2020 Apr.

Abstract

Novel coronavirus (nCoV) is a new emerging infectious agent causing coronavirus disease 2019 (COVID-19). Since the reporting of early cases of COVID-19 from China on December 29, 2019 till March 15, 2020, it has affected 1,42,539 humans in 135 countries, including 82 cases in India. As it is a difficult task for first-contact physicians, i.e. primary care and acute care physicians, to comprehend the fast-growing knowledge about nCoV and apply for prevention and care of suspected cases of COVID-19, we have tried to provide an updated capsule review of nCoV infection and management of COVID-19. It includes the evidence-based information on epidemiological determinants (agent, host, and environment) of the disease, its clinical features, clinical and laboratory diagnosis, basic infection prevention and control measures, and clinical management of COVID-19 cases. This review also includes the succinct summary of World Health Organization and Center for Diseases Control and Prevention interim guidelines (as of March 15, 2020) on nCoV.

摘要

新型冠状病毒(nCoV)是一种新出现的传染性病原体,可导致2019冠状病毒病(COVID-19)。自2019年12月29日中国报告COVID-19早期病例至2020年3月15日,它已在135个国家感染了142539人,其中印度有82例。由于对于一线医生,即初级保健医生和急症医生而言,理解关于nCoV快速增长的知识并应用于COVID-19疑似病例的预防和护理是一项艰巨的任务,我们试图提供一份关于nCoV感染及COVID-19管理的最新简要综述。它包括关于该疾病流行病学决定因素(病原体、宿主和环境)的循证信息、其临床特征、临床和实验室诊断、基本感染预防和控制措施以及COVID-19病例的临床管理。本综述还包括世界卫生组织和疾病控制与预防中心关于nCoV的临时指南(截至2020年3月15日)的简要总结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670c/7346926/7ede27b01724/JFMPC-9-1820-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验